3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Unknown
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Gastrointestinal
2
Thoracic
1
Other solid neoplasm
1
Gynecologic
1
Conditions
Ovarian Neoplasms
31
Peritoneal Neoplasms
28
Fallopian Tube Neoplasms
14
Stomach Neoplasms
13
Carcinoma, Ovarian Epithelial
13
Colorectal Neoplasms
11
Appendiceal Neoplasms
5
Neoplasm Metastasis
4
Uterine Neoplasms
3
Recurrence
3
Neoplasms
3
Uterine Cervical Neoplasms
2
Pseudomyxoma Peritonei
2
Pancreatic Neoplasms
2
Mesothelioma, Malignant
2
Mesothelioma
2
Colonic Neoplasms
2
Carcinoma
2
Sarcoma
1
Rhabdomyosarcoma
1
Rectal Neoplasms
1
Pleural Effusion
1
Peritoneal Diseases
1
Pelvic Neoplasms
1
Ovarian Epithelial Cancer Recurrent
1
Ovarian Cancer Recurrent
1
Liposarcoma
1
Krukenberg Tumor
1
Hyperthermia
1
Gastrointestinal Neoplasms
1
Interventions
Cisplatin
3
pembrolizumab
2
amminedichloro(2-methylpyridine)platinum(II)
2
Nivolumab
2
Cytoreduction Surgical Procedures
2
trastuzumab deruxtecan
1
trametinib
1
sodium thiosulfate
1
pertuzumab
1
pazopanib
1
osimertinib
1
motexafin gadolinium
1
fludarabine
1
danvatirsen
1
dabrafenib
1
cobimetinib
1
cemiplimab
1
alectinib
1
aldesleukin
1
X-Rays
1
Ritonavir
1
Remote Patient Monitoring
1
Patient-Specific Modeling
1
Pafolacianine
1
Oxaliplatin
1
Observation
1
Mitomycin
1
Microscopy, Electron
1
Itraconazole
1
Hyperthermic Intraperitoneal Chemotherapy
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Gastrointestinal Neoplasms
×
Hyperthermic Intraperitoneal Chemotherapy
×
Gynecologic
×
Clear all
NCT02349958
2019-04-16
HIPEC/IPHC
Bay Area Gynecology Oncology
Phase 2
Unknown
200 enrolled